Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: February 14, 2005
Last updated: April 27, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2005
  Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)